HVAX Technologies Limited

About  HVAX Technologies Limited

Founded in 2010, HVAX Technologies Limited has significantly transformed from its initial role as an HVAC project contractor to a leading provider of comprehensive turnkey solutions for controlled environment infrastructure and cleanrooms. The company specializes in the engineering, procurement, and execution of projects tailored primarily for the pharmaceutical sector, while also serving chemical companies, hospitals, healthcare providers, and FMCG firms. With a commitment to quality and innovation, HVAX has become a trusted partner for clients seeking reliable solutions in cleanroom technology and controlled environments.

HVAX Technologies excels in delivering end-to-end solutions that encompass the entire project lifecycle, from design and engineering to procurement, installation, testing, commissioning, and operational support. The company’s extensive portfolio includes a wide range of third-party manufactured products, such as cleanroom wall and ceiling panels, flooring systems, air handling units, and Building Management Systems (BMS). By providing comprehensive service offerings, HVAX ensures that its clients receive customized solutions that meet their specific requirements, reinforcing its reputation for excellence in project execution.

With a track record of completing around 200 projects across India and 15 countries—including Algeria, UAE, and South Africa—HVAX Technologies has established itself as a key player in the global market for controlled environments. 

At the core of HVAX Technologies’ operations is a dedicated team of 125 permanent and 21 temporary employees, complemented by skilled contract labor for project execution. The company prioritizes a client-centric approach, engaging directly with customers and collaborating with subcontractors to ensure timely and successful project outcomes. HVAX’s emphasis on high-quality, safe, and innovative solutions reflects its commitment to meeting the diverse needs of its clients in the pharmaceutical, healthcare, and biotech sectors, reinforcing its position as a leader in controlled environment solutions.

HVAX Technologies Limited prepares for its Initial Public Offering (IPO), the proceeds from the Fresh Issue will be allocated towards critical objectives

1. Funding the working capital requirements.
2. General Corporate Purpose.